Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
Randomized Controlled Trials as Topic
Trials can be designed using a wide array of possibilities. There is no 'one size fits all' solution. In order to make progress in the rare diseases, decisions to change practice will have to be based on less direct evidence from clinical trials than in more common diseases.